These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38068799)

  • 21. A newly isolated human intestinal bacterium strain capable of deglycosylating flavone C-glycosides and its functional properties.
    Zheng S; Geng D; Liu S; Wang Q; Liu S; Wang R
    Microb Cell Fact; 2019 May; 18(1):94. PubMed ID: 31138294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comprehensive mass spectrum analysis of two flavone-6,8-C-di-glycosides and its application by high resolution electrospray ionization tandem mass spectroscopy in both negative and positive ion modes].
    Wang XX; Li XB; Peng CS
    Zhongguo Zhong Yao Za Zhi; 2019 Nov; 44(22):4880-4887. PubMed ID: 31872596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of UGT1A1 by natural and synthetic flavonoids.
    Liu XY; Lv X; Wang P; Ai CZ; Zhou QH; Finel M; Fan B; Cao YF; Tang H; Ge GB
    Int J Biol Macromol; 2019 Apr; 126():653-661. PubMed ID: 30594625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extensive protein-protein interactions involving UDP-glucuronosyltransferase (UGT) 2B7 in human liver microsomes.
    Fujiwara R; Itoh T
    Drug Metab Pharmacokinet; 2014; 29(3):259-65. PubMed ID: 24366439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism.
    Court MH; Krishnaswamy S; Hao Q; Duan SX; Patten CJ; Von Moltke LL; Greenblatt DJ
    Drug Metab Dispos; 2003 Sep; 31(9):1125-33. PubMed ID: 12920168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
    Kaji H; Kume T
    Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in in vivo absorption of flavone glycosides, flavone aglycones and terpene lactones under different dosage forms and physiological conditions.
    Luo J; Ren H; Ye J; Wang X; Li P; Bai J; Lu Y; Du S
    J Ethnopharmacol; 2023 Apr; 306():116159. PubMed ID: 36649852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flavone deglycosylation increases their anti-inflammatory activity and absorption.
    Hostetler G; Riedl K; Cardenas H; Diosa-Toro M; Arango D; Schwartz S; Doseff AI
    Mol Nutr Food Res; 2012 Apr; 56(4):558-69. PubMed ID: 22351119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strong Specific Inhibition of UDP-glucuronosyltransferase 2B7 by Atractylenolide I and III.
    Zhang Q; Cao YF; Ran RX; Li RS; Wu X; Dong PP; Zhang YY; Hu CM; Wang WM
    Phytother Res; 2016 Jan; 30(1):25-30. PubMed ID: 26536846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uridine diphosphate glucuronosyltransferase isoform-dependent regiospecificity of glucuronidation of flavonoids.
    Singh R; Wu B; Tang L; Hu M
    J Agric Food Chem; 2011 Jul; 59(13):7452-64. PubMed ID: 21413806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New insights for the risk of bisphenol A: inhibition of UDP-glucuronosyltransferases (UGTs).
    Jiang HM; Fang ZZ; Cao YF; Hu CM; Sun XY; Hong M; Yang L; Ge GB; Liu Y; Zhang YY; Dong Q; Liu RJ
    Chemosphere; 2013 Oct; 93(6):1189-93. PubMed ID: 23948605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic polymorphisms in the 5'-flanking region of human UDP-glucuronosyltransferase 2B7 affect the Nrf2-dependent transcriptional regulation.
    Nakamura A; Nakajima M; Higashi E; Yamanaka H; Yokoi T
    Pharmacogenet Genomics; 2008 Aug; 18(8):709-20. PubMed ID: 18622263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucuronidation of active tamoxifen metabolites by the human UDP glucuronosyltransferases.
    Sun D; Sharma AK; Dellinger RW; Blevins-Primeau AS; Balliet RM; Chen G; Boyiri T; Amin S; Lazarus P
    Drug Metab Dispos; 2007 Nov; 35(11):2006-14. PubMed ID: 17664247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereoselective metabolism of racemic carvedilol by UGT1A1 and UGT2B7, and effects of mutation of these enzymes on glucuronidation activity.
    Takekuma Y; Takenaka T; Yamazaki K; Ueno K; Sugawara M
    Biol Pharm Bull; 2007 Nov; 30(11):2146-53. PubMed ID: 17978490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7.
    Tsoutsikos P; Miners JO; Stapleton A; Thomas A; Sallustio BC; Knights KM
    Biochem Pharmacol; 2004 Jan; 67(1):191-9. PubMed ID: 14667942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of substrates on the in vitro kinetics of steviol glucuronidation and interaction between steviol glycosides metabolites and UGT2B7.
    Chen JM; Xia YM; Zhang YD; Zhang TT; Peng QR; Fang Y
    Int J Food Sci Nutr; 2018 Jun; 69(4):472-479. PubMed ID: 28903608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interception of benzo[a]pyrene-7,8-dione by UDP glucuronosyltransferases (UGTs) in human lung cells.
    Zhang L; Huang M; Blair IA; Penning TM
    Chem Res Toxicol; 2013 Oct; 26(10):1570-8. PubMed ID: 24047243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mapping the UDP-glucuronic acid binding site in UDP-glucuronosyltransferase-1A10 by homology-based modeling: confirmation with biochemical evidence.
    Banerjee R; Pennington MW; Garza A; Owens IS
    Biochemistry; 2008 Jul; 47(28):7385-92. PubMed ID: 18570380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human uridine diphosphate-glucuronosyltransferase UGT2B7 conjugates mineralocorticoid and glucocorticoid metabolites.
    Girard C; Barbier O; Veilleux G; El-Alfy M; Bélanger A
    Endocrinology; 2003 Jun; 144(6):2659-68. PubMed ID: 12746330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Charactering the metabolism of cryptotanshinone by human P450 enzymes and uridine diphosphate glucuronosyltransferases in vitro.
    Zeng J; Fan YJ; Tan B; Su HZ; Li Y; Zhang LL; Jiang J; Qiu FR
    Acta Pharmacol Sin; 2018 Aug; 39(8):1393-1404. PubMed ID: 29417949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.